Medicines Transparency Alliance (MeTA): Pathways to Transparency, Accountability and Access. Cross-Case Analysis and Review of Phase II. May 25, 2016
(2016; 95 pages)

Resumen

The Medicines Transparency Alliance (MeTA) initiative, implemented in seven countries (Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia) from 2008 to 2015, sought to test the hypothesis that increasing transparency and accountability in the pharmaceutical sector would improve access to medicines by improving decision-making.

This study investigates the activities undertaken to increase transparency and foster accountability, and how these two goals are related to each other and to program outputs and outcomes. Focusing mainly on Phase II of MeTA (August 2011 – December 2015), we used case study methods and reviewed archival data to document transparency and accountability mechanisms. After completing the individual cases, we then conducted cross-case analysis to examine themes and note similarities and differences across countries.

Documentos relacionados
 
El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019